3-(cyclohexylamino)propanesulfonic acid Completed Phase 2 Trials for Steatohepatitis / Fatty Liver Treatment

Indications	Status	Purpose	Phase
DBCOND0013047 (Steatohepatitis) DBCOND0028942 (Fatty Liver)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01147523	Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease	3-(cyclohexylamino)propanesulfonic acid (DB02219) Spironolactone (DB00421) Vitamin E (DB00163)